These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 14630193)
1. Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands. Horner AA; Raz E Curr Opin Immunol; 2003 Dec; 15(6):614-9. PubMed ID: 14630193 [TBL] [Abstract][Full Text] [Related]
3. From plankton to pathogen recognition. Modlin RL; Cheng G Nat Med; 2004 Nov; 10(11):1173-4. PubMed ID: 15516915 [No Abstract] [Full Text] [Related]
4. Toll-like receptor ligands and atopy: a coin with at least two sides. Horner AA J Allergy Clin Immunol; 2006 May; 117(5):1133-40. PubMed ID: 16675343 [TBL] [Abstract][Full Text] [Related]
14. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195 [TBL] [Abstract][Full Text] [Related]
15. Wanted: a molecular basis for specificity in toll-like receptor signal transduction. O'Neill LA Mol Cell; 2002 Nov; 10(5):969-71. PubMed ID: 12453406 [No Abstract] [Full Text] [Related]
16. Immunology: a block at the toll gate. Mak TW; Yeh WC Nature; 2002 Aug; 418(6900):835-6. PubMed ID: 12192398 [No Abstract] [Full Text] [Related]
17. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling. Schmitz F; Mages J; Heit A; Lang R; Wagner H Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor ligands: hygiene, atopy and therapeutic implications. Horner AA; Redecke V; Raz E Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):555-61. PubMed ID: 15640699 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618 [TBL] [Abstract][Full Text] [Related]
20. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. Datta SK; Redecke V; Prilliman KR; Takabayashi K; Corr M; Tallant T; DiDonato J; Dziarski R; Akira S; Schoenberger SP; Raz E J Immunol; 2003 Apr; 170(8):4102-10. PubMed ID: 12682240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]